$450+ Million Herpes Marker Testing Market - Global Trajectory & Analytics to 2027 - ResearchAndMarkets.com

The "Herpes Marker Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Herpes Marker Testing Market to Reach $452.8 Million by 2027

Amid the COVID-19 crisis, the global market for Herpes Marker Testing estimated at US$328.6 Million in the year 2020, is projected to reach a revised size of US$452.8 Million by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027.

Viral Culture Test, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$111.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nucleic Acid Amplification-based Kits segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U. S. Market is Estimated at $96.8 Million, While China is Forecast to Grow at 4.4% CAGR

The Herpes Marker Testing market in the U. S. is estimated at US$96.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$80.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Antibody/Antigen-based Kits Segment to Record 4.2% CAGR

In the global Antibody/Antigen-based Kits segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$132.6 Million in the year 2020 will reach a projected size of US$177.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$52 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Abbott Laboratories
• Abcam PLC
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Luminex Corporation
• Merck KgaA
• Meridian Bioscience, Inc.
• Norgen Biotek Corporation
• Qiagen NV
• Quidel Corporation
• Teco Diagnostics
• Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Herpes Marker Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• Viral Culture Test (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
• Nucleic Acid Amplification-based Kits (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
• Antibody/Antigen-based Kits (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
• HSV-1 (Indication) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
• HSV-2 (Indication) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
• HSV-1/HSV-2 (Indication) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
• Research-Use (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
• Clinical Diagnostics (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
• Hospitals (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
• Diagnostic Centers (End-Use) Share Breakdown Review by Region/Country:2012 VS 2020 VS 2027
• Clinics (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
• Academic and Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/ox0730